{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:22:24Z","timestamp":1791912144116,"version":"4.3.4"},"reference-count":23,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2005,9,15]],"date-time":"2005-09-15T00:00:00Z","timestamp":1126742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Headache"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:p>Objective.\u2014To evaluate the efficacy of single doses of lumiracoxib, the most selective cyclo\u2010oxygenase (COX)\u20102 inhibitor, in the treatment of episodic tension\u2010type headache (ETTH), with particular emphasis on time to onset of analgesia.<\/jats:p>\n                  <jats:p>Background.\u2014ETTH is the most frequently occurring type of headache with an annual prevalence rate of up to 40%. Some patients with ETTH do not respond to currently available therapies, thus an effective analgesic is needed that provides a rapid onset of analgesia alongside significant pain relief. Lumiracoxib is the most selective COX\u20102 inhibitor developed for the treatment of acute and chronic pain.<\/jats:p>\n                  <jats:p>Methods.\u2014In this single\u2010center, randomized, double\u2010blind, double\u2010dummy, placebo\u2010controlled, parallel\u2010group study, patients with ETTH were randomly assigned to receive single\u2010dose lumiracoxib (200 or 400 mg, n = 60 in each group) or placebo (n = 30) within 1 hour of an ETTH. Efficacy was assessed over a 3\u2010hour period, the primary efficacy variable being the time to onset of analgesia. Other efficacy variables included summed pain intensity difference from 0 to 3 hours after dosing, time\u2010specific pain intensity difference, time\u2010specific pain relief, time\u2010specific pain relief intensity difference, total pain relief over 0 to 3 hours, patient's global evaluation of treatment effect, the proportion of patients who achieved onset of analgesia by 1 hour and time to rescue medication intake. Safety was assessed by monitoring and recording of all adverse events (AEs).<\/jats:p>\n                  <jats:p>\n                    Results.\u2014The median time to onset of analgesia was significantly faster for lumiracoxib 200 mg (47 minutes; 95% confidence interval [CI]: 41, 52) and lumiracoxib 400 mg (41 minutes; 95% CI: 36, 48) than for placebo (&gt;3 hours; both\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .001). Both doses of lumiracoxib were significantly superior to placebo for all secondary efficacy variables. There were no AEs recorded in any treatment group.\n                  <\/jats:p>\n                  <jats:p>Conclusions.\u2014Single 200 or 400 mg doses of lumiracoxib provided rapid and effective relief from the acute pain associated with ETTH.<\/jats:p>","DOI":"10.1111\/j.1526-4610.2005.00239.x","type":"journal-article","created":{"date-parts":[[2005,9,15]],"date-time":"2005-09-15T10:21:15Z","timestamp":1126779675000},"page":"1163-1170","source":"Crossref","is-referenced-by-count":12,"title":["Lumiracoxib Is Effective in the Treatment of Episodic Tension\u2010Type Headache"],"prefix":"10.1111","volume":"45","author":[{"given":"Elias","family":"Packman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Packman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Thurston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,9,15]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2003.00272.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.5.381"},{"issue":"7","key":"e_1_2_7_4_2","first-page":"64","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain","volume":"8","author":"International Headache Society: Headache Classification Subcommittee","year":"1988","journal-title":"Cephalalgia."},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2003.00574.x"},{"key":"e_1_2_7_6_2","first-page":"797","article-title":"Tension\u2010type headache","volume":"66","author":"Millea PJ","year":"2002","journal-title":"Am Fam Physician."},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-003-0063-8"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2003.00470.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/03009740310004766"},{"key":"e_1_2_7_10_2","first-page":"124","volume-title":"European Collaboration: Towards Drug Development and Rational Drug Therapy. Proceedings of the Sixth Congress of the European Association for Clinical Pharmacology and Therapeutics","author":"Hartmann S","year":"2003"},{"issue":"1","key":"e_1_2_7_11_2","first-page":"242","article-title":"Dose escalation study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of COX189 in healthy subjects","volume":"61","author":"Scott G","year":"2002","journal-title":"Ann Rheum Dis."},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2004.00156.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2004.00155.x"},{"key":"e_1_2_7_14_2","unstructured":"ChanV ClarkA DavisJ WolfR ForsytheA ManningD JayawardeneS.A comparison of COX189 naproxen and placebo for relief of post\u2010orthopedic surgery pain.World Congress on Pain (WCP) 2002 August 17\u201322 San Diego USA [Abstract 951\u2010P221]."},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2004.00179.x"},{"key":"e_1_2_7_16_2","first-page":"74","volume-title":"Survival Analysis","author":"Miller RG","year":"1981"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1996.tb04165.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2000.00087.x"},{"key":"e_1_2_7_19_2","unstructured":"KellsteinD JayawardeneS FrickeJJr.Lumiracoxib provides effective treatment of postoperative dental pain: results of three randomized controlled trials.British Pain Society (BPS) 2004 March 30\u2013April 2 Manchester UK[Abstract 16\u2010P16."},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.109353"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1996.tb04165.x"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1998.1803146.x"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1998.1801038.x"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200124150-00004"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1526-4610.2005.00239.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1526-4610.2005.00239.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:37:56Z","timestamp":1762087076000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/j.1526-4610.2005.00239.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,15]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1111\/j.1526-4610.2005.00239.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1526-4610.2005.00239.x","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,15]]}}}